Sania Therapeutics
PrivateLast Round
VC Round
May 21, 2024
Total Funding Raised
$6.55M
Momentum Score
25 /100
Company Overview
Sania Therapeutics is a biotechnology company that develops gene therapies intended to improve the quality of life of people with neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sania Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Sania Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 21, 2024 | ||||
| Seed | May 17, 2023 | ||||
| Seed | Mar 23, 2022 |
Sania Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SCI Ventures | Seed, VC Round |
| Grow London | VC Round |
| Arc Ventures | Seed |
| Axial VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 5, 2025
Monthly visitors increased 114% MoM.
- Oct 29, 2024
Monthly visitors increased 148% MoM.
Sania Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sania Therapeutics's valuation, stock price, and market status.
